Epidermal growth factor receptor expression and suramin cytotoxicity in vitro
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (8), 867-871
- https://doi.org/10.1016/0277-5379(90)90186-w
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Suramin, an anti‐cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2AFEBS Letters, 1989
- Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomasCancer, 1989
- Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell linesCancer Letters, 1988
- Blocking of EGF-Dependent Cell Proliferation by EGF Receptor Kinase InhibitorsScience, 1988
- Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: Establishment, characterization and response to cytotoxic treatmentEuropean Journal of Cancer and Clinical Oncology, 1988
- Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma-derived cell lines.Molecular and Cellular Biology, 1988
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cellsJournal of Cellular Physiology, 1987
- Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies.Journal of Biological Chemistry, 1984